Why the study?
Does a HAS-BLED score ≥ 3 predict major bleeding events in outpatients with VTE on long-term anticoagulation?
Does a HAS-BLED score ≥ 3 predict major bleeding events in outpatients with VTE on long-term anticoagulation?
The HAS-BLED score is useful for identifying VTE patients on long-term anticoagulation who are at high risk for major bleeding events.
No takes yet. Share an insight, caveat, or question.
May aid early bleeding risk stratification in VTE outpatients; leaves open validation across anticoagulant regimens in larger cohorts.
Raggam et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: